BLB SCIENTIFIC POSTERS

Hepatic fatty acid profile in chronic liver disease: mechanism of injury and novel therapeutic target

Boyer-Diaz Z, Domingo JC, Cordobilla B, Aristu-Zabalza P, Bosch J, Gracia-Sancho J.

AASLD, The Liver Meeting 

2019 Nov 8-12; Boston,
MA, United-States

Introducing a new pre-clinical model of advanced NASH that mimics the main pathophysiologic characteristics and transcriptomic signature of the human disease

Maeso-Díaz R, Boyer-Diaz Z, Peralta C, Bosch J, Gracia-Sancho J.

EASL – The International Liver Congress

2019 Apr 10-14; Vienna, Austria

Molecular mechanisms underlying the beneficial effects of emricasan in portal hypertension and chronic liver disease: relevance of the hepato-sinusoidal cross-talk

Gracia-Sancho J, Manicardi N, Ortega-Ribera M, Fernández-Iglesias A, Boyer-Diaz Z, Contreras PC, Spada A, Bosch J.

AASLD, The Liver Meeting

2018 Nov 9-13; San Francisco,
CA, United-States

Hepatocyte maintenance in vitro using an advanced microfluidic bioreactor for biomedical research and pharmaceutical applications

Ortega-Ribera M, Illa X, Fondevila C, Peralta C, Villa R, Gracia-Sancho J.

The International Liver Congress – EASL 

2016 Barcelona, Spain

 

μTAS, The 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences

2016 Oct 9-13; Dublin, Ireland